US6392071B1
(en)
*
|
1997-03-17 |
2002-05-21 |
Wisconsin Alumni: Research Foundation |
26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
|
US5945410A
(en)
*
|
1997-03-17 |
1999-08-31 |
Wisconsin Alumni Research Foundation |
2-alkyl-19-nor-vitamin D compounds
|
US6316642B1
(en)
*
|
1997-03-17 |
2001-11-13 |
Wisconsin Alumni Research Foundation |
26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
|
MA26481A1
(fr)
*
|
1997-04-21 |
2004-12-20 |
Hoffmann La Roche |
Derives d'arylsecocholadiene
|
US5936105A
(en)
*
|
1997-06-13 |
1999-08-10 |
Tetrionics, Inc. |
14-EPI-19-nor-vitamin D compounds and methods
|
US20030188756A1
(en)
*
|
2002-08-19 |
2003-10-09 |
Cantorna Margherita T |
Treatment of inflammatory bowel disease with vitamin d compounds
|
US6359012B1
(en)
*
|
1999-12-22 |
2002-03-19 |
Bone Care International, Inc. |
Method for making 24(S)-hydroxyvitamin D2
|
EP1286962B1
(en)
*
|
2000-05-31 |
2008-06-25 |
Wisconsin Alumni Research Foundation |
2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
|
JP2004505022A
(ja)
*
|
2000-07-14 |
2004-02-19 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーション |
骨強度を増加するための2−メチレン−19−ノル−20(S)−1α,25−ジヒドロキシビタミンD3の使用
|
BR0113703A
(pt)
|
2000-09-08 |
2003-07-22 |
Wisconsin Alumni Researcg Foun |
Compostos e métodos de tratamento de psorìase, leucemia, câncer do cólon, do seio ou da próstata, osteodistrofia renal, de doenças auto-imune, inflamatória e de condição de pele
|
SK11422003A3
(sk)
*
|
2001-03-15 |
2004-04-06 |
Basf Aktiengesellschaft |
5-Fenylpyrimidíny, spôsoby a medziprodukty na ich prípravu a ich použitie pri ničení škodlivých húb
|
US6683219B2
(en)
*
|
2001-07-30 |
2004-01-27 |
Wisconsin Alumni Research Foundation |
Synthesis of A-ring synthon of 19-nor-1α,25-dihydroxyvitamin D3 from (D)-glucose
|
NZ533424A
(en)
*
|
2001-12-13 |
2006-08-31 |
Wisconsin Alumni Res Found |
Vitamin D derivative, methods of purifying and uses in treating psoriasis, cancer, autoimmune diseases, inflammatory diseases, skin conidtions and renal ostepdystrophy
|
US6627622B2
(en)
*
|
2002-02-18 |
2003-09-30 |
Wisconsin Alumni Research Foundation |
(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
|
US6835723B2
(en)
*
|
2001-12-13 |
2004-12-28 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(S)-1α-hydroxy-bis-homo-pregnacalciferol in crystalline form
|
US6566352B1
(en)
|
2002-02-18 |
2003-05-20 |
Wisconsin Alumni Research Foudation |
1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
|
US6964784B2
(en)
*
|
2002-03-07 |
2005-11-15 |
Optigenex, Inc. |
Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
|
US20030195175A1
(en)
*
|
2002-03-25 |
2003-10-16 |
Deluca Hector F. |
Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
|
US6774251B2
(en)
*
|
2002-03-29 |
2004-08-10 |
Wisconsin Alumni Research Foundation |
Method of synthesizing 1α-hydroxy-2-methylene-19-nor-homopregnacalciferol
|
US6846811B2
(en)
*
|
2002-04-22 |
2005-01-25 |
Wisconsin Alumni Research Foundation |
(20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
|
US7259143B2
(en)
*
|
2002-09-05 |
2007-08-21 |
Wisconsin Alumni Research Foundation |
Method of extending the dose range of vitamin D compounds
|
US20080249068A1
(en)
*
|
2002-09-05 |
2008-10-09 |
Deluca Hector F |
Method of Extending the Dose Range of Vitamin D Compounds
|
EP1598360A4
(en)
|
2003-02-25 |
2010-04-07 |
Knc Lab Co Ltd |
NEW INTERMEDIATES FOR THE SYNTHESIS OF DERIVATIVES OF VITAMIN D
|
ATE556999T1
(de)
|
2003-04-10 |
2012-05-15 |
Wisconsin Alumni Res Found |
2-propyliden-19-nor-vitamin d verbindungen
|
US6894037B2
(en)
*
|
2003-07-03 |
2005-05-17 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
|
MXPA06000060A
(es)
*
|
2003-07-03 |
2006-04-07 |
Wisconsin Alumni Res Found |
2-metilen-19-nor-20(s)-25-metil-1alfa-hidroxicalciferol y sus usos.
|
US20050009792A1
(en)
*
|
2003-07-08 |
2005-01-13 |
Deluca Hector F. |
(20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
|
US20050209203A1
(en)
*
|
2003-07-30 |
2005-09-22 |
Jin Tian |
Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
|
JP5009617B2
(ja)
*
|
2003-08-20 |
2012-08-22 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−19−ノル−ビタミンd2化合物
|
WO2005027916A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
|
AU2004273659A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Wisconsin Alumni Research Foundation |
2-alkylidene-19-nor-vitamin D derivatives for the treatment of frailty, muscle damage or sarcopenia
|
WO2005027919A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture
|
WO2005027928A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
|
WO2005027913A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
|
BRPI0414448A
(pt)
*
|
2003-09-19 |
2006-11-14 |
Pfizer Prod Inc |
composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e um agonista/antagonista de estrogênio
|
WO2005027930A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylene-19-nor-vitamin d derivatives for the treatment of osteosarcoma
|
WO2005027918A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a cyclooxgenase-2 inhibitor
|
WO2005027922A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of hypogonadism or andropause
|
NZ545393A
(en)
*
|
2003-09-19 |
2009-10-30 |
Wisconsin Alumni Res Found |
2-Alkylidene-19-nor-vitamin D derivatives for the treatment of osteopenia or male osteoporosis
|
WO2005027920A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of rickets or vitamin d deficiency
|
WO2005027931A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist
|
WO2005027925A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of anorexia or low bone mass in females exhibiting aggressive athletic behavior
|
WO2005027929A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen
|
WO2005027926A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bone morphogenetic protein
|
NZ545803A
(en)
*
|
2003-09-19 |
2008-03-28 |
Wisconsin Alumni Res Found |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone
|
WO2005027921A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate
|
WO2005027927A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for enhancement of peak bone mass in adolescence
|
US7214670B2
(en)
*
|
2003-09-24 |
2007-05-08 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase the life expectancy of human beings
|
US7704980B2
(en)
*
|
2003-10-08 |
2010-04-27 |
Wisconsin Alumni Research Foundation |
Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
|
WO2005051396A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Deltanoid Pharmaceuticals, Inc. |
Methods for reducing body fat using vitamin d compounds
|
CA2544502A1
(en)
*
|
2003-11-25 |
2005-06-09 |
Wisconsin Alumni Research Foundation |
Vitamin d analogs for obesity prevention and treatment
|
US7915242B2
(en)
*
|
2004-02-17 |
2011-03-29 |
Wisconsin Alumni Research Foundation |
Vitamin D receptor antagonists and their use in treating asthma
|
US7214671B2
(en)
|
2004-02-19 |
2007-05-08 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
|
US7713951B2
(en)
*
|
2004-04-09 |
2010-05-11 |
Wisconsin Alumni Research Foundation |
2-alkylidene-18,19-dinor-vitamin D compounds
|
WO2006051106A1
(en)
|
2004-11-12 |
2006-05-18 |
Bioxell Spa |
Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
|
US7541348B2
(en)
*
|
2004-11-22 |
2009-06-02 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(20S)-1α-hydroxy-trishomopregnacalciferol
|
WO2006057932A2
(en)
*
|
2004-11-22 |
2006-06-01 |
Wisconsin Alumni Research Foundation |
2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES
|
WO2006057902A2
(en)
*
|
2004-11-22 |
2006-06-01 |
Wisconsin Alumni Research Foundation |
2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
|
AU2005309820B2
(en)
*
|
2004-11-22 |
2011-06-23 |
Wisconsin Alumni Research Foundation |
2-methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol
|
EP1828113B1
(en)
*
|
2004-11-22 |
2010-05-12 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
|
JP2008520705A
(ja)
*
|
2004-11-22 |
2008-06-19 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーション |
2−メチレン−19−ノル−1α−ヒドロキシ−17−エン−ホモプレグナカルシフェロールおよびその使用
|
AU2005309818A1
(en)
*
|
2004-11-22 |
2006-06-01 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(20R)-1-alpha-hydroxy-bishomopregnacalciferol
|
DK1848442T3
(da)
*
|
2005-02-11 |
2012-05-29 |
Wisconsin Alumni Res Found |
2-methylene-19-nor-(20s-24epi)-1alfa,25-dihydroxyvitamine-d2
|
MX2007009726A
(es)
*
|
2005-02-11 |
2007-09-26 |
Wisconsin Alumni Res Found |
2-metilen-19-nor-(20s-24s)-1a, 25-dihidroxivitamina-d2.
|
US7235680B2
(en)
*
|
2005-03-29 |
2007-06-26 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone
|
MX2007013558A
(es)
*
|
2005-05-03 |
2008-01-24 |
Wisconsin Alumni Res Found |
Compuestos de 19,26,27-trinor-1a,25-dihidroxivitamina d3.
|
CA2620354C
(en)
*
|
2005-08-30 |
2013-02-05 |
Wisconsin Alumni Research Foundation |
Des-c,d analogs of 1.alpha.,25-dihydroxy-19-norvitamin d3
|
WO2007038094A1
(en)
*
|
2005-09-22 |
2007-04-05 |
Wisconsin Alumni Research Foundation |
19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3
|
US7803789B2
(en)
*
|
2006-02-02 |
2010-09-28 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—RAK, methods and uses thereof
|
US7528122B2
(en)
*
|
2006-02-02 |
2009-05-05 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—NEL, methods and uses thereof
|
US20090281340A1
(en)
*
|
2006-04-05 |
2009-11-12 |
Deluca Hector F |
1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and treatment thereof
|
US8058265B2
(en)
*
|
2006-04-05 |
2011-11-15 |
Wisconsin Alumni Research Foundation |
1a-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereof
|
EP2021321B1
(en)
*
|
2006-04-06 |
2012-06-20 |
Wisconsin Alumni Research Foundation |
2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
|
NZ570814A
(en)
*
|
2006-04-06 |
2011-11-25 |
Wisconsin Alumni Res Found |
2-methylene-1alpha-hydroxy-19,21-dinorvitamin D3 analogs and uses thereof
|
CA2646911A1
(en)
*
|
2006-04-06 |
2008-03-27 |
Hector F. Deluca |
2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof
|
US8193169B2
(en)
*
|
2006-04-06 |
2012-06-05 |
Wisconsin Alumni Research Foundation |
(20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
|
US7648973B2
(en)
*
|
2006-04-06 |
2010-01-19 |
Wisconsin Alumni Research Foundation |
2-methylene-1α,25-dihydroxy-19,21-dinorvitamin D3 analogs and uses thereof
|
EP2001860A2
(en)
*
|
2006-04-06 |
2008-12-17 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring
|
EP2001841B1
(en)
*
|
2006-04-06 |
2012-06-13 |
Wisconsin Alumni Research Foundation |
2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
|
ATE496885T1
(de)
*
|
2006-04-10 |
2011-02-15 |
Wisconsin Alumni Res Found |
1-alpha-hydroxy-2-(3'-hydroxypropyliden)-19-nor vitamin-d-verbindungen mit einer 1,1- dimethylpropyl-seitenkette
|
EP2069296B1
(en)
*
|
2006-09-28 |
2012-04-04 |
Wisconsin Alumni Research Foundation |
2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
|
AU2007300214A1
(en)
*
|
2006-09-28 |
2008-04-03 |
Wisconsin Alumni Research Foundation |
2-methylene-(20R,25S)-19,27-dinor-(22E)-vitamin D analogs
|
US20080171728A1
(en)
*
|
2007-01-12 |
2008-07-17 |
Quatrx Pharmaceuticals Co. |
Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone
|
EP2237837B1
(en)
*
|
2007-12-28 |
2012-08-22 |
Wisconsin Alumni Research Foundation |
(20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
|
US7718637B2
(en)
*
|
2007-12-28 |
2010-05-18 |
Wisconsin Alumni Research Foundation |
(20S)-23,23-difluoro-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs
|
AU2008345085A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Wisconsin Alumni Research Foundation |
2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs
|
ATE552239T1
(de)
*
|
2007-12-28 |
2012-04-15 |
Wisconsin Alumni Res Found |
2-methylen-20-methyl-19,24,25,26,27-pentanor- vitamin-d-analoga
|
MX2010007264A
(es)
*
|
2007-12-28 |
2011-03-15 |
Wisconsin Alumni Res Foundation Star |
Análogos de vitamina d 2-metilen-(20s, 25r)-19, 26-dinor.
|
AU2009206449B2
(en)
*
|
2008-01-22 |
2014-04-24 |
Wisconsin Alumni Research Foundation |
13,13-Dimethyl-des-C,D analogs of 1alpha, 25-dihydroxy-19-nor-vitamin D3 compounds and topical composition dosage forms and methods of treating skin conditions
|
US8222236B2
(en)
*
|
2008-07-10 |
2012-07-17 |
Wisconsin Alumni Research Foundation |
2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
|
US7713953B2
(en)
*
|
2008-07-10 |
2010-05-11 |
Wisconsin Alumni Research Foundation |
2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
|
US7879829B2
(en)
*
|
2008-07-10 |
2011-02-01 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 1,2-dihydrofuran ring
|
US7888339B2
(en)
|
2008-07-10 |
2011-02-15 |
Wisconsin Alumni Research Foundation |
2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
|
US7648974B1
(en)
*
|
2008-07-10 |
2010-01-19 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 3,2-dihydrofuran ring
|
US7893043B2
(en)
|
2008-07-10 |
2011-02-22 |
Wisconsin Alumni Research Foundation |
2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
|
US8193170B2
(en)
|
2008-07-10 |
2012-06-05 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
|
US8399439B2
(en)
*
|
2008-07-10 |
2013-03-19 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
|
US20120115824A1
(en)
*
|
2009-04-17 |
2012-05-10 |
Vidasym, Llc |
Vitamin D Receptor Agonists and Uses Thereof
|
CA2764577C
(en)
*
|
2009-08-03 |
2017-12-19 |
Wisconsin Alumni Research Foundation |
Method of preventing renal disease and treating symptoms thereof
|
WO2011041596A2
(en)
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin d analogs with 1,2-or 3,2-cyclopentene ring
|
WO2011041599A2
(en)
*
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
6-methylvitamin d3 analogs and their uses
|
WO2011041590A2
(en)
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
|
JP2013506685A
(ja)
|
2009-10-02 |
2013-02-28 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーション |
(20S,22E)−2−メチレン−19−ノル−22−エン−1α,25−ジヒドロキシビタミンD3類似体
|
CA2777938C
(en)
*
|
2009-10-21 |
2017-11-14 |
Wisconsin Alumni Research Foundation |
Method of preventing type 1 diabetes
|
US8604009B2
(en)
*
|
2010-03-23 |
2013-12-10 |
Wisconsin Alumni Research Foundation |
(20S)-2-methylene-19-nor-22-dimethyl-1α,25-dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22-dimethyl-1α,25-hydroxyvitamin D3
|
US8664206B2
(en)
|
2010-03-23 |
2014-03-04 |
Wisconsin Alumni Research Foundation |
Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
|
AU2011232562B2
(en)
|
2010-03-23 |
2014-10-02 |
Wisconsin Alumni Research Foundation |
Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25- dihydroxyvitamin D3
|
AU2011308911B2
(en)
|
2010-09-30 |
2014-10-02 |
Wisconsin Alumni Research Foundation |
(20R,25S)-2-methylene-19,26-dinor-1alpha, 25-dihydroxyvitamin D3 in crystalline form
|
US8754067B2
(en)
|
2010-11-12 |
2014-06-17 |
Wisconsin Alumni Research Foundation |
22-haloacetoxy-homopregnacalciferol analogs and their uses
|
US9290447B2
(en)
|
2011-05-03 |
2016-03-22 |
Wisconsin Alumni Research Foundation |
(20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses
|
WO2012158794A1
(en)
|
2011-05-17 |
2012-11-22 |
Wisconsin Alumni Research Foundation |
N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
|
JP6059716B2
(ja)
|
2011-06-03 |
2017-01-11 |
ウイスコンシン アラムニ リサーチ ファンデーション |
(22E)−2−メチレン−26,27−シクロ−22−デヒドロ−1α−ヒドロキシ−19−ノルビタミンD3誘導体
|
JP6035331B2
(ja)
*
|
2011-06-14 |
2016-11-30 |
ウイスコンシン アラムニ リサーチ ファンデーション |
3−デスオキシ−2−メチレン−19−ノル−ビタミンd類似体およびそれらの使用
|
US10479764B2
(en)
|
2011-06-28 |
2019-11-19 |
Wisconsin Alumni Research Foundation |
2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
|
WO2013012644A1
(en)
|
2011-07-18 |
2013-01-24 |
Wisconsin Alumni I Research Foundation |
2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs
|
WO2013032846A1
(en)
|
2011-08-26 |
2013-03-07 |
Wisconsin Alumni Research Foundation |
2-METHYLENE-19,23,24-TRINOR-1α-HYDROXYVITAMIN D3
|
AU2012301422B2
(en)
|
2011-08-30 |
2016-11-10 |
Wisconsin Alumni Research Foundation |
Crystallization of 1 alpha-hydroxy-20-methylene-19,24,25,26,27-pentanorvitamin D3
|
US8420839B1
(en)
|
2011-10-05 |
2013-04-16 |
Wisconsin Alumni Research Foundation |
Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol
|
JP6072811B2
(ja)
*
|
2011-10-21 |
2017-02-01 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−ビタミンd類似体およびそれらの使用
|
JP6114292B2
(ja)
*
|
2011-10-21 |
2017-04-12 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−ビタミンd類似体およびそれらの使用
|
US8729054B2
(en)
|
2011-10-21 |
2014-05-20 |
Wisconsin Alumni Research Foundation |
3-desoxy-2-methylene-vitamin D analogs and their uses
|
US8884039B2
(en)
|
2012-05-30 |
2014-11-11 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1α,25-dihydroxyvitamin D3
|
US8940916B2
(en)
*
|
2012-05-30 |
2015-01-27 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3
|
US9212137B2
(en)
|
2012-05-30 |
2015-12-15 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 and related precursors
|
US9040728B2
(en)
|
2012-05-30 |
2015-05-26 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R) 19-nor-24-difluoro-1α,25-dihydroxyvitamin D3
|
US8785422B2
(en)
|
2012-06-06 |
2014-07-22 |
Wisconsin Alumni Research Foundation |
A-ring modified 19-nor-vitamin D analogs and their uses
|
AU2013281217B2
(en)
|
2012-06-29 |
2017-03-02 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism
|
EP2746252A1
(en)
|
2012-12-21 |
2014-06-25 |
Wisconsin Alumni Research Foundation (WARF) |
Crystallization of 1alpha-hydroxy-2-methylene- 18,19-dinor-homopregnacalciferol
|
US9416102B2
(en)
|
2013-01-23 |
2016-08-16 |
Wisconsin Alumni Research Foundation |
(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs
|
US10369161B2
(en)
|
2014-12-30 |
2019-08-06 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism
|
US9539264B2
(en)
|
2014-12-30 |
2017-01-10 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics
|
EP3317250B1
(en)
|
2015-05-26 |
2020-09-09 |
Wisconsin Alumni Research Foundation |
(20s)-1alpha,25-dihydroxy-24,24-difluoro-19-nor-vitamin d3 analogs and their pharmaceutical uses
|
US20170296558A1
(en)
|
2016-04-18 |
2017-10-19 |
Wisconsin Alumni Research Foundation |
Use of 2amd and 2md to treat fibrosis
|
WO2018044468A1
(en)
|
2016-08-30 |
2018-03-08 |
Wisconsin Alumni Research Foundation |
COMBINATION OF LOW DOSE 2-METHYLENE-19-NOR-(20S)-1α, 25-DIHYDROXYVITAMIN D3 AND CALCIMIMETICS TO TREAT SECONDARY HYPERPARATHYROIDISM
|